889 related articles for article (PubMed ID: 29945808)
41. Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Vamos M; Cappato R; Marchlinski FE; Natale A; Hohnloser SH
Europace; 2016 Dec; 18(12):1787-1794. PubMed ID: 26797248
[TBL] [Abstract][Full Text] [Related]
42. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
[TBL] [Abstract][Full Text] [Related]
43. Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.
Márquez MF; Baños-González MA; Guevara-Valdivia ME; Vázquez-Acosta J; de Los Ríos Ibarra MO; Aguilar-Linares JA; Jiménez-Cruz M; Matadamas-Hernández N; Camacho-Casillas R; Magaña-Magaña R; Rojel-Martínez U; Alcocer-Gamba MA; Lara-Vaca S; Rodríguez-Reyes H; Islava-Gálvez MA; Betancourt-Hernández LE; Reyes-Reyes N; Beltrán-Gámez ME; Cantú-Brito C; Baños-Velasco AZ; Del Rivero Morfin PJ; González-Hermosillo JA
Glob Heart; 2020 Apr; 15(1):32. PubMed ID: 32489805
[TBL] [Abstract][Full Text] [Related]
44. Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis.
Liu M; Wang Y; Chen X; Li X; Zhuang X; Wang L
Medicine (Baltimore); 2017 Dec; 96(48):e8479. PubMed ID: 29310330
[TBL] [Abstract][Full Text] [Related]
45. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
[TBL] [Abstract][Full Text] [Related]
46. Non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy patients undergoing catheter ablation of atrial fibrillation.
Creta A; Hunter RJ; Earley MJ; Finlay M; Dhinoja M; Sporton S; Chow A; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2626-2631. PubMed ID: 32639666
[TBL] [Abstract][Full Text] [Related]
47. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation.
Rahman H; Khan SU; DePersis M; Hammad T; Nasir F; Kaluski E
Cardiovasc Revasc Med; 2019 Feb; 20(2):147-152. PubMed ID: 29786530
[TBL] [Abstract][Full Text] [Related]
48. New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin.
Zhao Y; Yang Y; Tang X; Yu X; Zhang L; Xiao H
J Interv Card Electrophysiol; 2017 Apr; 48(3):267-282. PubMed ID: 28078536
[TBL] [Abstract][Full Text] [Related]
49. Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants.
Doi A; Takagi M; Kakihara J; Hayashi Y; Tatsumi H; Fujimoto K; Sugioka K; Yoshiyama M
Heart Vessels; 2017 Oct; 32(10):1227-1235. PubMed ID: 28466408
[TBL] [Abstract][Full Text] [Related]
50. Catheter ablation of atrial fibrillation with uninterrupted anticoagulation: a meta-analysis of six randomized controlled trials.
Di Monaco A; Guida P; Vitulano N; Quadrini F; Troisi F; Langialonga T; Grimaldi M
J Cardiovasc Med (Hagerstown); 2020 Jul; 21(7):483-490. PubMed ID: 32040031
[TBL] [Abstract][Full Text] [Related]
51. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
52. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
53. Comparison of major bleeding events of uninterrupted non-vitamin K antagonist oral anticoagulants versus uninterrupted vitamin K antagonist during catheter ablation of atrial fibrillation: a meta-analysis of randomised controlled trials.
Yang Q; Chen X; Zhai J; Dang Y
Acta Cardiol; 2022 May; 77(3):257-263. PubMed ID: 33871328
[TBL] [Abstract][Full Text] [Related]
54. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
[TBL] [Abstract][Full Text] [Related]
56. Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
Cardoso R; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Brouwer MA; Calkins H
Clin Cardiol; 2019 Jan; 42(1):198-205. PubMed ID: 30460702
[TBL] [Abstract][Full Text] [Related]
57. No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
Zweiker D; Manninger M; Sieghartsleitner R; Ebner J; Pratl B; Bisping E; Lercher P; von Lewinski D; Riedlbauer R; Rohrer U; Spronk HMH; Zirlik A; Schotten U; Scherr D
Int J Cardiol; 2021 May; 331():106-108. PubMed ID: 33508338
[TBL] [Abstract][Full Text] [Related]
58. Stroke and thromboembolism prevention in atrial fibrillation.
Jame S; Barnes G
Heart; 2020 Jan; 106(1):10-17. PubMed ID: 31533990
[TBL] [Abstract][Full Text] [Related]
59. Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation.
Müller P; Halbfass P; Szöllösi A; Dietrich JW; Fochler F; Nentwich K; Roos M; Krug J; Schmitt R; Mügge A; Deneke T
J Interv Card Electrophysiol; 2016 Sep; 46(3):203-11. PubMed ID: 27020439
[TBL] [Abstract][Full Text] [Related]
60. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
